참고문헌
- 강희갑, 박준우. TRIPS 협정의 의약품 특허와 공중보건논의에 관한 미국의 입장과 대응방안. 산업재산권 2006 ; 20 : 79-108.
- 김남규. 특허발명의 강제실시제도 : 의약품 접근권 향상을 위한 제도개선을 중심으로. 법과 정책연구 2006 ; 6(2) : 805-824.
- 김홍국. 조류독감약 ‘강제실시권’ 검토. 문화일보 2005년 10월 31일자.
- 남희섭. 공공의 이익을 위한 특허발명의 강제실시. 창작과 권리 2003 ; 30 : 77-108.
- 남희섭. 특허발명의 강제실시. 2008. Available from : URL : http://www.ipleft.or.kr/node/ 2484
- 배은영. 약제비 증가의 기여요인과 영향분석. 보건경제와 정책연구 2007 ; 13(2) : 39-54.
- 배은영, 정연, 이병란. 의약품 등재가 결정방식 및 개선방안 연구. 건강보험심사평가원 : 2008.
- 보건복지부. 국민건강보험 요양급여의 기준에 관한 규칙 일부개정령(안) 및 신의료기술 등의 결정 및 조정기준 개정(안) 입법예고. 2006.
- 서환주, 정동진, 송종국. 특허권강화는 기술혁신을 촉진하는가 : 한국의 특허법개혁을 중심으로. 국제경제연구 2004 ; 10(2) : 183-216.
- 안영진. 식약청, 인체감염 조류독감 비상땐 타미플루 카피약 생산 고려. 한겨레신문 2005년 10월 20일자.
- 양희진. 자유무역협정과 지적재산권 강화, 어떻게 대응할 것인가, 진보평론 2005 ; 23 :101-123.
- 오준병, 장원창. 특허권 강화와 기술혁신에 관한 실증연구 : 우리나라의 제 11차 특허법 개혁을 중심으로. 경제학연구 2008 ; 56(2) : 63-90.
- 육소영. 특허법상 강제실시권의 연구. 충남대학교 법학연구 2005 ; 16(1) : 117-140.
- 이수연. 다국적 제약자본의 지적재산권 보호 대 국민 건강권 보장간의 갈등. 사회복지연구 2004 ; 23 : 139-168.
- 이영수. 제약사 비싼 약값 요구, 약가협상 결렬 원인. 국민일보 쿠키뉴스 2009년 10월 15일. Available from : URL : http : //news.kukinews.com/article/view.asp?page=1&gCode=kmi&arcid=1255591314&cp=nv
- 이익희 특허발명의 강제실시제도 공중보건문제 . : 해결을 위한 제도개선을 중심으로. 특허청 : 2005.
- 이준규. 신종플루 치료제 ‘타미플루’ 복제품 국내 생산하게 해야. 경향신문 2009년 5월 21 일자.
- 정명진, 이병관, 정윤택, 정아영, 장진영. 2008년 의약품산업 분석보고서. 한국보건산업진흥원 : 2008.
- 한국보건산업진흥원. 제약산업 실태분석. 2008.
- Abott FM, Reichman JH. The Doha Round's Public Health Legacy : Strategies for the Production and Diffusion of Patented Medicines under the Amended TRIPS Provisions. Journal of International Economic Law 2007 ; 10(4) : 921-987. https://doi.org/10.1093/jiel/jgm040
- Arndt HW. GATT and the developing world : Agenda for a new trade round. Review of World Economics 1987 ; 123(4) : 705-718.
- Azra J. How Can State Provide Affordable Pharmaceuticals to the Underserved? Journal of Health Care for the Poor and Underserved 2006 ; 17(4):808-820. https://doi.org/10.1353/hpu.2006.0138
- Bale HE Jr. Industry, innovation and social values. Sci Eng Ethics 2005 ; 11(1):31-40. https://doi.org/10.1007/s11948-005-0053-9
- Berndt ER. Pharmaceuticals in U.S. health care : Determinants of quantity and price. The Journal of Economic Perspectives 2002 ; 16 : 45–66.
- Bird RC. Defending Intellectual Property Rights in the BRIC Economies. Am Bus Law J 2006 ; 43(2) : 317-363. https://doi.org/10.1111/j.1744-1714.2006.00019.x
- Cahoy DR. The Impact of Compulsory Licensing on Foreign Direct Investment: A Collective Bargaining Approach. American Business Law Journal 2008 ; 45(2) : 299-300.
- Chaudhuri S. The WTO and India's Pharmaceuticals Industry : Patent Protection, Trips, and Developing Countries. New Delhi : Oxford University Press : 2005.
- Chien C. Cheap Drugs at What Price to Innovation: Does the Compulsory Licensing of Pharmaceuticals Hurt Innovation? Berkeley Technology Law Journal 2003 ; 8 : 853-908.
- Cohen J, Cairns C, Paquette C, Faden L. Comparing Patient Access to Pharmaceuticals in the UK and US. Appl Health Econ Helath Policy 2006 ; 5(3) : 177-187. https://doi.org/10.2165/00148365-200605030-00004
- Commission on Intellectual Property Rights(CIPR). Integrating Intellectual Property Rights and Development Policy. CIPR : 2002.
- Cugno F, Ottoz E. Static Efficiency of Compulsory Licensing: Price Vs. Quantity Competition June 9, 2006. Available from: URL : http : //ideas.repec.org/p/uto/dipeco/200606.html.
- Danzon PM, Wang YR, Wang L. The Impact of Price Regulation on the Launch Delay of New Drugs- Evidence from Twenty-five Major Markets in the 1990s. Health Economics 2005 ; 14 : 269-292. https://doi.org/10.1002/hec.931
- Drahos P. Global Property Rights in Information : The story of TRIPS at the GATT. Prometheus 1995 ; 13(1) : 6-19. https://doi.org/10.1080/08109029508629187
- Drahos P, Braithwaite J. Intellectual property, corporate strategy, globalisation : TRIPS in context. Wisconsin International Law Journal 2002 ; 20(3) : 451- 480.
- Health Intervention and Technology Assessment Program(HITAP). Final Report-Assessing the Implication of Thailand‘s Government Use Licenses, Issued in 2006-2008. HITAP : 2009.
- Ho CM. Patent Breaking or Balancing? Separating Strands of Fact from Fiction Under TRIPS. North Carolina Journal of International Law and Commercial Regulation 2009 ; 34(2) : 371-470.
- International Trade Administration. Pharmaceutical Price Controls in OECD Countries. U.S. Department of Commerce : 2004.
- Lee KW. Permitted use of patented inventions in the United States : Why Prescription drugs do not merit compulsory Licensing. Indiana Law Review. 2003 ; 36 : 175.
- Azra J. How Can State Provide Affordable Pharmaceuticals to the Underserved? Journal of Health Care for the Poor and Underserved 2006 ; 17(4) : 808-820. https://doi.org/10.1353/hpu.2006.0138
- Light DW. In the name of research: Raising drug prices here and abroad 15 Dec. 2004, Available from : URL : http : //www.cptech.org/ip/health/rnd/dlight12152004.ppt
- Lybecker KM, Fowlerd E. Compulsory Licensing in Canada and Thailand: Comparing Regimes to Ensure Legitimate Use of the WTO Rules,” Journal of Law, Medicine & Ethics 2009 ; 37(2) : 222-240. https://doi.org/10.1111/j.1748-720X.2009.00367.x
- Moser P. Compulsory Licensing Evidence from the Trading with the Enemy Act. Stanford University Department of Economics 2008-2009 seminar series 2009.
- Nishimura M. Analysis of the Political Processes for the Formation of the TRIPs Agreement : With the Focus on the Pharmaceutical Industry and the Computer Industry in Japan, Europe, and the United States. Available from : URL : http : //www.iip.or.jp/e/summary/pdf/detail2006/e18_28.pdf.
- NIHCM Foundation, Prescription Drugs & IPP, Issue Brief August 2000.
- Organisation for Economic Co-operation and Development(OECD). Pharmaceutical Pricing Policies in a Global Market. OECD : 2008.
- Paris V, Docteur E. Pharmaceutical Pricing and Reimbursement Policies in Canada. OECD Health Working Papers. OECD : 2006.
- Permanand G, Altenstetter C. The Politics of Pharmaceuticals in the European Union. In : Mossialos E, Mrazek M, Walley T, editors. Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. Open University Press ; 2004. pp. 40-51.
- Pugatch MP. The International Political Economy of Intellectual Property Rights. Edward Elgar ; 2004. pp.129.
- Putnam R. Diplomacy and Domestic Politics, International organization : The Logic of Two-Level Games. International Organization 1988 ; 42(3) : 427-460. https://doi.org/10.1017/S0020818300027697
- Reichman JH. Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options. J Law Med Ethics 2009 ; 37(2) : 247-263. https://doi.org/10.1111/j.1748-720X.2009.00369.x
- Russell S. Bird flu drug maker won't share patent. San Francisco Chronicle. October 13, 2005.
- Sell SK. Intellectual Property Rights. In : Held D, McGrew A, editors. Governing Globalization : Power, authority and Global Governance. MA : Blackwell Publishers ; 2002. pp. 171-188.
- Thomas C. Trade policy and the politics of access to drugs. Third World Quarterly 2002 ; 23(2) : 251-264. https://doi.org/10.1080/01436590220126621
- Van Overwalle G, Van Zimmeren E. Reshaping Belgian Patent Law : The Revision of the Research Exemption and the Introduction of a Compulsory License for Public Health. IIP Forum (Japanese journal) 2006 ; 64 : 42-4. Available from : URL : http : //www.iip.or.jp/e/forum/vol64_overwalle_and_zimmeren.pdf
- Werhane PH, Gorman M. Intellectual property rights, moral imagination, and access to life-enhancing drugs. Bus Ethics Q 2005 ; 15(4) : 595-613. https://doi.org/10.5840/beq200515441
- World Trade Organization(WTO). Agreement on Trade-Related Aspects of Intellectual Property Rights. WTO : 1994 Available from : URL : http : //www.wto.org/english/docs_e/legal_e/27-trips.pdf.
- World Trade Organization(WTO). Declaration on the TRIPS agreement and public health, Adopted on 14 November 2001. Available from:URL : http : //www.wto. org/english/theWTO_e/minist_e/min01_e/mindecl_trips_e.htm.
- World Trade Organization(WTO) Website. Compulsory licensing. FACT SHEET : TRIPS AND PHARMACEUTICAL PATENTS ; Obligations and exceptions. September 2006 Available from : URL : http : //www.wto.org/english/tratop_e/ trips_e/factsheet_pharm02_e.htm#compulsorylicensing.
- Wright T. Roche Plans Big Increase in Tamiflu Production. New York Times, November 10, 2005. Available from: URL : http : //www.nytimes.com/2005/ 11/10/business/worldbusiness/10roche.html
- Yeh BT. Influenza Antiviral Drugs and Patent Law Issues. CRS Report for Congress ; Congressional Research Service : 2005.
피인용 문헌
- Compulsory licensing of pharmaceuticals reconsidered: Current situation and implications for access to medicines pp.1744-1706, 2017, https://doi.org/10.1080/17441692.2017.1407811